GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Asap3 | decreases expression | ISO | ASAP3 (Homo sapiens) | 6480464 | CTD | Valproic Acid results in decreased expression of DDEFL1 mRNA | PMID:23527032 | Asap3 | increases expression | ISO | ASAP3 (Homo sapiens) | 6480464 | CTD | Valproic Acid results in increased expression of ASAP3 mRNA | PMID:26272509 | Asap3 | increases methylation | ISO | ASAP3 (Homo sapiens) | 6480464 | CTD | Valproic Acid results in increased methylation of ASAP3 gene | PMID:29154799 | Asap3 | multiple interactions | ISO | ASAP3 (Homo sapiens) | 6480464 | CTD | [Hydralazine co-treated with Valproic Acid] results in increased expression of DDEFL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASAP3 mRNA | PMID:17183730 PMID:27188386 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |